Bringing science to life

Clinical insights

The importance of T cell fitness in cancer immunotherapy

The efficacy of cancer immunotherapies can vary among patients, with a range of factors influencing treatment effect. One of these factors is T cell fitness.

Leadership & innovation

Innovation: A relentless commitment to learning and impact

Innovation is not a destination; it is a journey defined by curiosity, courage, and a relentless commitment to learning.

Leadership & innovation

Adaptive clinical trials: Accelerating the future of immunotherapy

As we celebrate medical and scientific advances, we must also recognize the challenges in how we evaluate and deliver new treatments.

Clinical insights

Overall Response Rate and solid tumors – the magic number… to date

With the rise of immunotherapies for cancer, the limitations of RECIST-based evaluation are becoming more important.